The ATA promotes thyroid awareness and information through Clinical Thyroidology , a resource that summarizes research for patients and families, and extensive, authoritative resources on thyroid disease and thyroid cancer in both English and Spanish
Oral Wegovy costs between $149-$299 per month without insurance according to Novo Nordisk's January 2026 announcement
Nielsen, R
Retatrutide is an investigational triple-receptor medication being studied for GIP, GLP-1, and glucagon receptor activity
Women with PCOS, perimenopause, or insulin resistance Patients with GI sensitivity or history of medication intolerance Individuals seeking metabolic or hormonal balance without rapid weight loss Patients who want to layer GLP-1s with lifestyle changes, not use them as a crutch Is Microdosing Less Effective
The Joi + Blokes GLP-1 page includes this disclosure directly on the product page